News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
Publication
Dermatology Times
More
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
    • Biologic Treatments for Moderate to Severe Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
    • Emerging Therapies Plaque Psoriasis
    • Treatments for Plaque Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Skin Cancer (Nonmelanoma)
  • Vitiligo
  • Wound Care
Spotlight -
NP and PA
Advertisement

Ahmad Amin, MD, FAAD

Advertisement

Articles by Ahmad Amin, MD, FAAD

Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAAD

ByEmma Andrus, Assistant Editor,Ahmad Amin, MD, FAAD
June 24th 2023

Ahmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.

Advertisement

Latest Updated Articles

  • Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAAD
    Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAAD

    Published: June 24th 2023 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria

2

KT-621 Produces 98% STAT6 Degradation in AD Patients

3

Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema

4

Site-Specific MED Variability Guides 308-nm Excimer Laser Dosing

5

Impaired HRQoL and High Psychological Comorbidity Observed in Japanese Vitiligo Patients

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us